Trial Profile
An open-label, single sequence study to assess the potential pharmacokinetic drug-drug interaction of elinogrel and atorvastatin at steady-state in healthy adult subjects
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Elinogrel (Primary)
- Indications Acute coronary syndromes; Embolism and thrombosis; Hyperlipidaemia; Myocardial infarction
- Focus Pharmacokinetics
- 18 Jan 2012 Status changed from not yet recruiting to discontinued.
- 27 Apr 2011 New trial record